Lataa...
Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
The first study demonstrating that human colorectal carcinoma (CRC) is under robust immunosurveillance was published a decade ago. Today, it is clear that CRC patients with Stage III lesions abundantly infiltrated by effector memory T cells have a better prognosis than subjects with Stage I neoplasm...
Tallennettuna:
| Julkaisussa: | Oncoimmunology |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485723/ https://ncbi.nlm.nih.gov/pubmed/26140250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1058597 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|